cannabinoid CB2 agonists (Grunenthal)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Namecannabinoid CB2 agonists (Grunenthal)

Drug Alias Namecannabinoid CB2 agonists (Temple University)O-1966O-3853

ClassificationSmall molecules

Mechanisms of ActionCannabinoid CB2 receptor agonistsImmunomodulators

TargetsCannabinoid CB2 receptor

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTemple University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGrünenthal GmbH

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

ATC CodeN/A